Recent Advances in the Treatment of Advanced HER2+ Breast Cancer: SABCS 2024 - Episode 10
Novel and Emerging Strategies for HER2+ Breast Cancer With Brain Metastases
Panelists discuss how sequential therapy selection for patients with HER2+ breast cancer with progressive brain metastases requires careful consideration of prior treatments, patterns of progression, symptom burden, and available clinical trials, while balancing the need for both systemic disease control and CNS -specific approaches.
Video content above is prompted by the following:
How do you approach the treatment of patients with HER2-positive breast cancer with brain metastases who experience relapse or progression, and what factors guide your choice of therapy?
Related Content:
